Galectin Therapeutics GALT
NASDAQ GALT
$3.37 -0.06 (-1.75%)
At close: Oct 21, 2026 · 4:00 PM EDT

Galectin Therapeutics (GALT) Total Debt (2024 - 2026)

Updated

Galectin Therapeutics' Total Debt was $33.04 million in Q2 2026.

Analysis

Galectin Therapeutics (GALT) Total Debt (2024 - 2026) Analysis & Trends

At the end of FY2024, Total Debt at Galectin Therapeutics came in at $21.12 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 Galectin Therapeutics 222.99 Mn 166.33 Mn - 33.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.04 Mn
Sep 30, 2025 32.52 Mn
Mar 31, 2025 21.28 Mn
Dec 31, 2024 21.12 Mn
Sep 30, 2024 10.52 Mn
API Access

Galectin Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=GALT&period=max&api_key=YOUR_API_KEY